These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29152493)

  • 1. A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals.
    Summers EM; Blickenstaff NR; Coman GC; Martins TB; Hill HR; Sontheimer RD
    Ann Transl Med; 2017 Oct; 5(20):393. PubMed ID: 29152493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers.
    Summers EM; Bingham CS; Dahle KW; Sweeney C; Ying J; Sontheimer RD
    JAMA Dermatol; 2013 Jul; 149(7):814-8. PubMed ID: 23636109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study.
    Joly P; Benoit-Corven C; Baricault S; Lambert A; Hellot MF; Josset V; Barbaud A; Courville P; Delaporte E; Collet E; Carvalho P; Modeste-Duval AB; Lacour JP; L'Anthoën-Arditi MH; Thuillez C; Benichou J
    J Invest Dermatol; 2007 Dec; 127(12):2766-71. PubMed ID: 17713574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.
    Shiga Y; Miura SI; Motozato K; Yoshimine Y; Norimatsu K; Arimura T; Koyoshi R; Morii J; Kuwano T; Inoue K; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Clin Med Res; 2017 Feb; 9(2):98-103. PubMed ID: 28090225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging.
    Brummer GC; Wang LT; Sontheimer RD
    Dermatol Online J; 2018 Feb; 24(2):. PubMed ID: 29630150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort Study.
    Hopkins AM; Lerner K; Grinich E; Ahn J; Choi Y; Hanifin J; Simpson E
    Dermatitis; 2023; 34(5):419-424. PubMed ID: 37172272
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ; Carter BL
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the losartan-hydrochlorothiazide combination tablet in patients with hypertension uncontrolled by angiotensin II receptor antagonist therapy: the Aichi Research on Combination therapy for Hypertension (ARCH) Study.
    Maeda K; Adachi M; Kinoshita A; Koh N; Miura Y; Murohara T
    Intern Med; 2012; 51(10):1167-75. PubMed ID: 22687785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis.
    Girardi M; Duncan KO; Tigelaar RE; Imaeda S; Watsky KL; McNiff JM
    Am J Dermatopathol; 2005 Aug; 27(4):343-6. PubMed ID: 16121058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children.
    Haw WY; Polak ME; McGuire C; Erlewyn-Lajeunesse M; Ardern-Jones MR
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):61-6. PubMed ID: 27221062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs.
    Fardal Ø; Lygre H
    J Clin Periodontol; 2015 Jul; 42(7):640-6. PubMed ID: 26076712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.